<DOC>
<DOCNO>EP-0659184</DOCNO> 
<TEXT>
<INVENTION-TITLE>
OPTICALLY ACTIVE HYDROQUININE (AMINO-3 PHENYL)-1 ETHANESULFONATE, PREPARATION AND USE THEREOF
</INVENTION-TITLE>
<CLASSIFICATIONS>C07C30924	C07K5078	C07B5300	A61K3800	C07C30900	C07D45304	A61K3800	C07K500	C07D45300	C07B5300	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07C	C07K	C07B	A61K	C07C	C07D	A61K	C07K	C07D	C07B	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07C309	C07K5	C07B53	A61K38	C07C309	C07D453	A61K38	C07K5	C07D453	C07B53	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate (form A), preparation thereof and its use as an intermediate in the preparation of cholecystokinine and gastrin antagonists.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
RHONE POULENC RORER SA
</APPLICANT-NAME>
<APPLICANT-NAME>
RHONE-POULENC RORER S.A.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
GUYON CLAUDE
</INVENTOR-NAME>
<INVENTOR-NAME>
GUYON, CLAUDE
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Optically active hydroquinine 1- (3-aminophenyl) - 
ethanesulphonate (Form A) obtainable by the process 

comprising the following stages: 

a) action of an alkali metal sulphite on (RS)-1- 
(1-bromoethyl) -3-nitrobenzene in aqueous medium at 

a temperature of between 50 and 100°C and passage to 
the potassium salt in order to obtain potassium 

(RS) -1 - (3 nitrophenyl) ethanesulphonate, 
b) conversion of the potassium (RS)-1-(3-nitrophenyl)-ethanesulphonate 
to benzylquininium 1- (3-nitro-phenyl) 

ethanesulphonate whose melting point is about 
110°C and whose optical rotation [α]
 20 / D is -151.3° ± 
1.5 (C = 1.009%; methanol), by means of an N-benzylquininium 

halide, in the presence of potassium 
dihydrogen phosphate, in aqueous medium, at a temperature 

of between 10 and 30°C and separation of 
the product by recrystallization from 2-propanol, 
c) reduction of the benzylquininium 1- (3-nitrophenyl)-ethanesulpbonate 
Form A obtained in b) by means of 

hydrogen under pressure, in the presence of a catalyst, 
at a temperature of between 10°C and 30°C. 
Process for the preparation of optically active 
hydroquinine 1- (3-aminophenyl) ethanesulphonate (Form A), 

characterized in that it comprises the following stages: 

a) action of an alkali metal sulphite on (RS)-1- 
(1-bromoethyl) -3-nitrobenzene in aqueous medium at 

a temperature of between 50 and 100°C and passage to 
the potassium salt in order to obtain potassium 

(RS)-1- (3-nitrophenyl) ethanesulphonate, 
b) conversion of the potassium (RS) -1- (3-nitrophenyl)-ethanesulphonate  
 

to benzylquininium 1-(3-nitrophenyl) 
ethanesulphonate whose melting point is about 

110°C and whose optical rotation [α] 20 / D is -151.3 ° ± 

1.5 (C = 1.009%; methanol), by means of an N-benzylquininium 
halide, in the presence of potassium 

dihydrogen phosphate, in aqueous medium, at a temperature 
of between 10 and 30°C and separation of 

the product by recrystallization from 2-propanol, 
c) reduction of the benzylquininium 1-(3-nitrophenyl)-ethanesulphonate 
Form A obtained in b) by means of 

hydrogen under pressure, in the presence of a catalyst, 
at a temperature of between 10°C and 30°C. 
Process according to claim 2, in the case of 
which stage a) is performed at 80°C. 
Process according to claim 2, in the case of 
which in stage a) the product is recovered by being 

converted into a tetraalkylammonium or trialkylphenyl-alkylammonium 
salt and then into a potassium salt. 
Process according to claim 2, in the case of 
which in stage c) the operation is carried out at a 

hydrogen pressure of 100 kPa. 
Use of the compound according to claim 1 for the 
preparation of the active enantiomer of compounds of 

formula: 

 
in which Y denotes: 


A) a -CH₂-CO-NR₁R₂ residue in which R₁ denotes a radical 
which is (a) phenyl optionally substituted by one or more 

substituents chosen from halogen atoms and alkyl, alkoxy, 
hydroxyl, polyfluoroalkyl, nitro, alkylthio, alkoxycarbonyl, 

carboxyl, acylamino, methylenedioxy, polyfluoroalkoxy, 
trifluoromethylthio, phenoxy, phenyl, benzyl, phenyl-amino 

and CONR₃R₄, radicals in which R₃ and R₄, which are 
identical or different, denote a hydrogen atom, an alkyl, 

phenyl (optionally substituted by one or more substituents  
 

chosen from halogen atoms and alkyl, alkoxy and 
alkylthio radicals), indanyl, cycloalkylalkyl, cycloalkyl 

or phenylalkyl radical or else R₃ and R₄ together with 
the nitrogen atom to which they are attached form a 

saturated or unsaturated mono- or polycyclic heterocyclic 
ring containing 4 to 9 carbon atoms and one or more 

heteroatoms (O, N, S) and optionally substituted by one 
or more alkyl, alkoxy, alkoxycarbonyl, dialkylcarbamoyl 

or phenyl radicals or in combination with a carbon atom 
of the heterocyclic ring by a 4- or 5-membered spiromonocyclic 

ring optionally oontaining one or more heteroatoms 
(O, S, N); (b) pyridyl, (c) isoquinolyl, (d) quinolyl, 

(e) quinoxalinyl (these heterocyclic rings being 
optionally substituted by one or more substituents chosen 

from alkyl and phenyl radicals and halogen atoms), (f) 
alkyl, (g) phenylalkyl, (h) naphthyl, (i) 5,6,7,8-tetrahydronaphthyl, 

(j) 1,2,3,4-tetrahydronaphthyl, (k) 
alkoxycarbonylalkyl or (l) cycloalkyl,
 
R₂ denotes a -CH(R₅)-CO-R₆ chain in which R₅ denotes a 

hydrogen atom or an alkyl, alkoxycarbonyl or phenyl 
radical (optionally substituted by one or more substituents 

chosen from halogen atoms and alkyl, alkoxy, alkylthio, 
nitro and amino radicals) and R₆ denotes an alkoxy, 

cycloalkyloxy (optionally substituted by at least one 
alkyl radical), cycloalkylalkyloxy, phenylalkyloxy, 

polyfluoroalkyloxy, cinnamyloxy and -NR₃R₄ radical, 
B) a residue of formula; 

 
in which: 


either R denotes a methylene, ethylene, SO, SO₂ or CHOH 
radical or a sulphur atom, R₇ denotes a pyridyl radical 

optionally substituted by one or more alkyl radicals,  
 

furyl optionally substituted by one or more alkyl 
radicals, thienyl optionally substituted by one or more 

alkyl radicals, quinolyl optionally substituted by one or 
more alkyl radicals, naphthyl optionally substituted by 

one or more alkyl radicals, indolyl optionally substituted 
by one or more alkyl radicals or phenyl optionally 

substituted by one or more substituents chosen from 
halogen atoms and alkyl, alkoxy, hydroxyl, nitro, amino, 

monoalkylamino, dialkylamino, alkoxycarbonyl, -CO-NR₁₁R₁₂, 
-NH-CO-CH₃, trifluoromethyl or trifluoromethoxy radicals 

and R₈ denotes a hydrogen atom, 
or R denotes a methylene radical, R₇ denotes a hydrogen 
atom and R₈ denotes a phenyl radical, 
or R denotes a radical CHR₁₃, each of R₇ and R₈ denotes 
a hydrogen atom, 
R₉ denotes an alkoxycarbonyl, cycloalkyloxycarbonyl, 
cycloalkylalkyloxycarbonyl, -CONR₁₄R₁₅ or phenyl radical 

optionally substituted by one or more substituents chosen 
from alkyl, alkoxy or hydroxyl radicals, 
R₁₀ denotes a hydrogen atom or an alkyl radical, 
R₁₃ denotes a phenyl radical, 
R₁₁ denotes a hydrogen atom or an alkyl, phenylalkyl or 
phenyl radical optionally substituted by one or more 

substituents chosen from halogen atoms and alkyl, alkoxy 
and alkylthio radicals, 
R₁₂ denotes an alkyl, phenylalkyl or phenyl radical 
optionally substituted by one or more substituents chosen 

from halogen atoms and alkyl, alkoxy and alkylthio 
radicals, 
 
or else R₁₁ and R₁₂ with the nitrogen atom to which they 

are attached form a saturated or unsaturated mono- or 
polycyclic heterocyclic ring containing 4 to 9 carbon 

atoms and one or more heteroatoms (O,N) and optionally 
substituted by one or more alkyl radicals, 


R₁₄ denotes a hydrogen atom or an alkyl, cycloalkyl-alkyl, 
cycloalkyl, phenylalkyl or phenyl radical optionally 

substituted by one or more substituents chosen from 
halogen atoms and alkyl, alkoxy and alkylthio radicals, 
R₁₅ denotes an alkyl, cycloalkylalkyl, cycloalkyl,  
 

phenylalkyl or phenyl radical optionally substituted by 
one or more substituents chosen from halogen atoms and 

alkyl, alkoxy and alkylthio radicals, 
 
or else R₁₄ and R₁₅ together with the nitrogen atom to 

which they are attached form a saturated or unsaturated 
mono- or polycyclic heterocyclic ring containing 4 to 

9 carbon atoms and one or more heteroatoms (O,N,S) and 
optionally substituted by one or more alkyl radicals, 
C) a residue of formula: 

 
in which: 


R₁₆ denotes a hydrogen or halogen atom or an alkyl, 
alkylthio, nitro, hydroxyl or cyano radical, 
R₁₇ denotes an alkyl radical or a -CH(R₅)-CO-R₆ residue, 
R₁₈ denotes a pyridyl or phenyl radical optionally 
substituted by one or more substituents chosen from 

halogen atoms and alkyl, alkoxy, hydroxyl, carboxyl and 
nitro radicals. 
</CLAIMS>
</TEXT>
</DOC>
